Latest News in the pharma Industry

All

Skyepharma set-up for serialization and aggregation, ready for Russian market

Skyepharma set-up for serialization and aggregation, ready for Russian market

20 Jan 2020

Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for serialization and aggregation.

Read more 
CURE sees delivery platform as springboard for success

CURE sees delivery platform as springboard for success

20 Jan 2020

In this exclusive interview, CURE Pharmaceutical COO Jessica Rousset explains her company’s dual pharmaceutical/nutraceutical approach and why the cannabinoid space is ripe for drug delivery innovation

Read more 
Meet Sai Life Sciences at CPhI, Japan 2020

Meet Sai Life Sciences at CPhI, Japan 2020

20 Jan 2020

Sai Life Sciences will be in Tokyo for CPhI Japan 2020 during March 16-18, 2020. Please visit booth # 1C - 50 and explore opportunities for collaboration. To schedule an appointment, email [email protected]

Read more 
CPhI World Wide

CPhI World Wide

17 Jan 2020

CPhI Worldwide houses six zones representing each stage of the pharmaceutical supply chain - from APIs, machinery and packaging to outsourcing and biopharmaceuticals. Uniting over 45,000 visiting attendees and 2,500 international exhibitors, this ...

Read more 
Wuxi to acquire Bayer final drug product manufacturing site

Wuxi to acquire Bayer final drug product manufacturing site

17 Jan 2020

First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.

Read more 
Bosch Packaging Technology is now Syntegon

Bosch Packaging Technology is now Syntegon

16 Jan 2020

Business to focus on intelligent and sustainable technologies.

Read more 
Pioneer in Phenylketonuria to begin clinical trial with gene therapy

Pioneer in Phenylketonuria to begin clinical trial with gene therapy

15 Jan 2020

BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.

Read more 
GHO Capital acquires Ardena

GHO Capital acquires Ardena

14 Jan 2020

GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

Read more 
French regulator agrees to partial resumption of Tellomak trial patient recruitment

French regulator agrees to partial resumption of Tellomak trial patient recruitment

14 Jan 2020

The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ...

Read more 
Biogen to acquire novel clinical-stage asset from Pfizer

Biogen to acquire novel clinical-stage asset from Pfizer

14 Jan 2020

PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases.

Read more 
Catalent launches direct-to-patient clinical supply services

Catalent launches direct-to-patient clinical supply services

14 Jan 2020

Multiple options provide increased flexibility for sponsors.

Read more 
Partnership formed to develop and commercialise ready-to-use medicine

Partnership formed to develop and commercialise ready-to-use medicine

13 Jan 2020

The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products.

Read more